相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of raltegravir intensification on HIV proviral DNA in the blood and gut mucosa of men on long-term therapy: a randomized controlled trial
Duncan Chege et al.
AIDS (2012)
Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors
Mohammad M. Sajadi et al.
AIDS (2012)
Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-Specific Redistribution Effect That Results in Increased Extracellular Viral Load
Victor G. Kramer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study
Josep M. Llibre et al.
ANTIVIRAL THERAPY (2012)
Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: Multicenter AIDS Cohort Study
Rulin C. Hechter et al.
ATHEROSCLEROSIS (2012)
Effects of Recombinant Human Interleukin 7 on T-Cell Recovery and Thymic Output in HIV-Infected Patients Receiving Antiretroviral Therapy: Results of a Phase I/IIa Randomized, Placebo-Controlled, Multicenter Study
Y. Levy et al.
CLINICAL INFECTIOUS DISEASES (2012)
Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis
Georgios N. Kalambokis et al.
HEPATOLOGY (2012)
Statin Therapy Decreases Serum Levels of High-Sensitivity C-Reactive Protein and Tumor Necrosis Factor-α in HIV-Infected Patients Treated With Ritonavir-Boosted Protease Inhibitors
Leonardo Calza et al.
HIV CLINICAL TRIALS (2012)
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-Infected Patients Receiving Antiretroviral Therapy
Rajesh T. Gandhi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy A Randomized Controlled Trial
Nicholas I. Paton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Inflammation, Immune Activation, and CVD Risk in Individuals With HIV Infection
James H. Stein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Epstein-Barr Virus load and immune activation in Human Immunodeficiency Virus type 1-infected patients
Maria Raffaella Petrara et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
A Pilot Trial of Adding Maraviroc to Suppressive Antiretroviral Therapy for Suboptimal CD4+ T-Cell Recovery Despite Sustained Virologic Suppression: ACTG A5256
Timothy J. Wilkin et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Cytomegalovirus Immunoglobulin G Antibody Is Associated With Subclinical Carotid Artery Disease Among HIV-Infected Women
Christina M. Parrinello et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Adaptive immunity in obesity and insulin resistance
Henrike Sell et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Microbial translocation in HIV infection: causes, consequences and treatment opportunities
Netanya G. Sandler et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load
Stephane De Wit et al.
AIDS (2011)
HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons
Chun Chao et al.
AIDS (2011)
High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors
Elisabeth Aslangul et al.
AIDS (2011)
Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
Renata Micha et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders
Stefania Piconi et al.
BLOOD (2011)
In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells
R. Rossi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
Giovanni Guaraldi et al.
CLINICAL INFECTIOUS DISEASES (2011)
Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells
Andrea Mencarelli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations With Immune Activation
Collin L. Ellis et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Intensification of Antiretroviral Therapy With Raltegravir or Addition of Hyperimmune Bovine Colostrum in HIV-Infected Patients With Suboptimal CD4+ T-Cell Response: A Randomized Controlled Trial
Helen Byakwaga et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Valganciclovir Reduces T Cell Activation in HIV-infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
Anuradha Ganesan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
Michael M. Lederman et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Relationship Between Residual Plasma Viremia and the Size of HIV Proviral DNA Reservoirs in Infected Individuals Receiving Effective Antiretroviral Therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy
Viktor Dahl et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the COPA pilot randomized trial
A. Gori et al.
MUCOSAL IMMUNOLOGY (2011)
Association between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients
Richard D. Moore et al.
PLOS ONE (2011)
Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected
Carolina Gutierrez et al.
PLOS ONE (2011)
Effect of Probiotic Bacteria on Microbial Host Defense, Growth, and Immune Function in Human Immunodeficiency Virus Type-1 Infection
Susanna Cunningham-Rundles et al.
NUTRIENTS (2011)
Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy
Mark A. Wallet et al.
AIDS (2010)
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
Steven A. Yukl et al.
AIDS (2010)
Chloroquine Modulates HIV-1-Induced Plasmacytoid Dendritic Cell Alpha Interferon: Implication for T-Cell Activation
Jeffrey A. Martinson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Sevelamer Decreases Systemic Inflammation in Parallel to a Reduction in Endotoxemia
A. E. M. Stinghen et al.
BLOOD PURIFICATION (2010)
Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy
D. McMahon et al.
CLINICAL INFECTIOUS DISEASES (2010)
Causes of Death in HIV-1-Infected Patients Treated with Antiretroviral Therapy, 1996-2006: Collaborative Analysis of 13 HIV Cohort Studies
John Gill et al.
CLINICAL INFECTIOUS DISEASES (2010)
Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy
Aylin Yilmaz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087
Carl J. Fichtenbaum et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Human Cytomegalovirus Induces Systemic Immune Activation Characterized by a Type 1 Cytokine Signature
Pablo J. van de Berg et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Biological Determinants of Immune Reconstitution in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Interleukin 7 and Interleukin 7 Receptor α and Microbial Translocation
Reena Rajasuriar et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Reduction of Immune Activation with Chloroquine Therapy during Chronic HIV Infection
Shannon M. Murray et al.
JOURNAL OF VIROLOGY (2010)
Effect of treating co-infections on HIV-1 viral load: a systematic review
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2010)
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J. Buzon et al.
NATURE MEDICINE (2010)
Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease
David M. Naeger et al.
PLOS ONE (2010)
Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+Cell Infection
Nancie M. Archin et al.
PLOS ONE (2010)
Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort
L Cuzin et al.
Journal of the International AIDS Society (2010)
Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
J. Vlachogiannakos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients
H-J Epple et al.
GUT (2009)
CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation
Jose F. Camargo et al.
JOURNAL OF IMMUNOLOGY (2009)
Serum Immune Activation Markers Are Persistently Increased in Patients with HIV Infection after 6 Years of Antiretroviral Therapy despite Suppression of Viral Replication and Reconstitution of CD4+ T Cells
Martyn A. French et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection
Wei Jiang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanism
Phyllis P. Sun et al.
KIDNEY INTERNATIONAL (2009)
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
J. B. Dinoso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Differential Th17CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
Jason M. Brenchley et al.
BLOOD (2008)
The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006
Marc C. Hochberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations
E. A. Debbia et al.
JOURNAL OF CHEMOTHERAPY (2008)
Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation
Prameet M. Sheth et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques
V. Cecchinato et al.
MUCOSAL IMMUNOLOGY (2008)
Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication
Tohti Amet et al.
MICROBES AND INFECTION (2008)
Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection
Theophillis S. Vijaykumar et al.
VIROLOGY (2008)
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis
Andrea Gori et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Immunomodulation by statins: Inhibition of cholesterol vs. isoprenoid biosynthesis
Hedwich F. Kuipers et al.
BIOMEDICINE & PHARMACOTHERAPY (2007)
Effect of chloroquine on reducing HIV-I replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes
Marloes A. Naarding et al.
RETROVIROLOGY (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
MK Jain et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner
M Rutz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Statin-induced immunomodulatory effects on human T cells in vivo
T Fehr et al.
ATHEROSCLEROSIS (2004)
The ability of chloroquine to prevent Tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity
F Rayne et al.
JOURNAL OF VIROLOGY (2004)
New Scientific Paradigms for Probiotics and Prebiotics
Gregor Reid et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
Severe CD4(+) T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
M Guadalupe et al.
JOURNAL OF VIROLOGY (2003)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Molecular action of methotrexate in inflammatory diseases
ESL Chan et al.
ARTHRITIS RESEARCH (2002)
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis
M Cutolo et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Statins as a newly recognized type of immunomodulator
B Kwak et al.
NATURE MEDICINE (2000)
分享论文
